Collplant Biotechnologies Ltd (CLGN) — Cash Flow-to-Debt Ratio
Collplant Biotechnologies Ltd (CLGN) has a Cash Flow-to-Debt Ratio of -0.60x as of September 2025, meaning its operating cash flow of $-2.88 Million could theoretically repay -1% of its total liabilities ($4.78 Million) in one year. Explore CLGN strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Collplant Biotechnologies Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Collplant Biotechnologies Ltd across 13 annual periods. Also explore Collplant Biotechnologies Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Collplant Biotechnologies Ltd (2012–2024)
Year-by-year debt coverage analysis for Collplant Biotechnologies Ltd. For market capitalisation and broader financial context, see CLGN market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.69x | $-14.09 Million | $5.25 Million | ▼ -462.7% |
| 2023 | -0.48x | $-2.76 Million | $5.79 Million | ▲ +80.9% |
| 2022 | -2.50x | $-13.70 Million | $5.49 Million | ▼ -709.2% |
| 2021 | 0.41x | $2.50 Million | $6.10 Million | ▲ +158.6% |
| 2020 | -0.70x | $-4.45 Million | $6.36 Million | ▲ +18.3% |
| 2019 | -0.86x | $-5.70 Million | $6.66 Million | ▼ -201.7% |
| 2018 | -0.28x | $-1.22 Million | $4.29 Million | ▲ +68.8% |
| 2017 | -0.91x | $-4.97 Million | $5.46 Million | ▲ +56.3% |
| 2016 | -2.08x | $-5.02 Million | $2.41 Million | ▲ +46.2% |
| 2015 | -3.87x | $-3.72 Million | $960.64K | ▲ +20.8% |
| 2014 | -4.89x | $-3.33 Million | $679.77K | ▼ -17.3% |
| 2013 | -4.17x | $-3.82 Million | $915.72K | ▲ +13.9% |
| 2012 | -4.84x | $-3.86 Million | $797.87K | — |